Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Smadja

Showing results (201-210 of 225) with videos related to

Pageof 23
Sort By:
Thrombosis Research|November 15, 2020
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control studyBenjamin Planquette, Alice Le Berre, Lina Khider, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2020
Curative anticoagulation prevents endothelial lesion in COVID-19 patientsLina Khider, Nicolas Gendron, Guillaume Goudot, et al.
Stem Cell Reviews and Reports|November 18, 2020
Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 CellsCoralie L Guerin, Léa Guyonnet, Guillaume Goudot, et al.
Angiogenesis|June 29, 2021
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspectsDavid M Smadja, Steven J Mentzer, Michaela Fontenay, et al.
Frontiers in Medicine|December 7, 2020
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular AfterloadGuillaume Goudot, Richard Chocron, Jean-Loup Augy, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortalityDavid M Smadja, Aurélien Philippe, Olivier Bory, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
The Journal of Experimental Medicine|December 20, 2023
A conserved transcriptional program for MAIT cells across mammalian evolutionHélène Bugaut, Yara El Morr, Martin Mestdagh, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Pageof 23

Showing results (201-210 of 225) with videos related to

Sort By:
Pageof 23
Thrombosis Research|November 15, 2020
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control studyBenjamin Planquette, Alice Le Berre, Lina Khider, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2020
Curative anticoagulation prevents endothelial lesion in COVID-19 patientsLina Khider, Nicolas Gendron, Guillaume Goudot, et al.
Stem Cell Reviews and Reports|November 18, 2020
Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 CellsCoralie L Guerin, Léa Guyonnet, Guillaume Goudot, et al.
Angiogenesis|June 29, 2021
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspectsDavid M Smadja, Steven J Mentzer, Michaela Fontenay, et al.
Frontiers in Medicine|December 7, 2020
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular AfterloadGuillaume Goudot, Richard Chocron, Jean-Loup Augy, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortalityDavid M Smadja, Aurélien Philippe, Olivier Bory, et al.
Thrombosis and Haemostasis|February 10, 2022
Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)Benjamin Planquette, Lina Khider, Alice Le Berre, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
The Journal of Experimental Medicine|December 20, 2023
A conserved transcriptional program for MAIT cells across mammalian evolutionHélène Bugaut, Yara El Morr, Martin Mestdagh, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Pageof 23